Skip to main content

CORRECTION article

Front. Endocrinol., 27 September 2022
Sec. Pediatric Endocrinology
Volume 13 - 2022 | https://doi.org/10.3389/fendo.2022.1020804

Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature

This article is a correction to:

  1. GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature

    1. Read original article
Anja Apel&#x;Anja Apel1†Daniel I. Iliev&#x;Daniel I. Iliev1†Christina UrbanChristina Urban1Karin WeberKarin Weber1Roland SchweizerRoland Schweizer1Gunnar BlumenstockGunnar Blumenstock2Sarah PascheSarah Pasche3Vanessa NieratschkerVanessa Nieratschker3Gerhard Binder*Gerhard Binder1*
  • 1Pediatric Endocrinology, University Children`s Hospital Tübingen, Tübingen, Germany
  • 2Department of Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany
  • 3Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health, University Hospital Tübingen, Tübingen, Germany

A Corrigendum on:
GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature

by Apel A, Iliev DI, Urban C, Weber K, Schweizer R, Blumenstock G, Pasche S, Nieratschker V and Binder G (2022) Front. Endocrinol. 13:897897. doi: 10.3389/fendo.2022.897897

In the published article, there was an error in Table 1. The values of height SDS at and after start of treatment were wrong. The corrected Table 1 and its caption "Clinical characteristics and GHR polymorphism status of the patients (mean ± SD)" appear below.

TABLE 1
www.frontiersin.org

Table 1 Clinical characteristics and GHR polymorphism status of the patients (mean ± SD).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: IGF-1, promotor methylation, GH response, prediction, short stature, GH treatment

Citation: Apel A, Iliev DI, Urban C, Weber K, Schweizer R, Blumenstock G, Pasche S, Nieratschker V and Binder G (2022) Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature. Front. Endocrinol. 13:1020804. doi: 10.3389/fendo.2022.1020804

Received: 16 August 2022; Accepted: 12 September 2022;
Published: 27 September 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Apel, Iliev, Urban, Weber, Schweizer, Blumenstock, Pasche, Nieratschker and Binder. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Gerhard Binder, gerhard.binder@med.uni-tuebingen.de

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.